Cardiomyopathy and Myosin Studies
Moving in European Heart Journal, Journal of the American College of Cardiology, Cardiovascular Research, Circulation Research, bioRxiv, JAMA Cardiology, Frontiers in Genetics and JACC: Basic to Translational Science.
- Moved, week to 17 Nov 2026
- 0
- Papers in 60 days
- 85
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Cardiomyopathy and Myosin Studies
Newest first · last 60 days
AI summary · may contain errors
Cardiac magnetic resonance (CMR) is positioned as an established tool for assessing cardiac patients, with practical guidance for general cardiologists across common heart-disease categories.
- Open access
AI summary · may contain errors
In reconstituted cardiac myosin II ensembles, pharmacological perturbations (omecamtiv mecarbil or mavacamten) make force generation depend on initial effective motor occupancy, not myosin number alone.
- Open access
AI summary · may contain errors
Diastolic function measured in human iPSC-cardiomyocytes carrying TNNI3 variants correlates with disease severity, with age at onset linked by R² = 0.6 in patients from a single site.
- Open access
- 2 cites
AI summary · may contain errors
A single-AAV, cardiomyocyte-specific adenine base editor corrected the MYBPC3 Dutch founder mutation (c.2827C>T, p.Arg943Ter) and ameliorated cardiac hypertrophy in an HCM mouse model.
- Open access
AI summary · may contain errors
In 508 hypertrophic cardiomyopathy patients with prior negative NGS testing, retesting with an updated panel found HCM-related variants in 9% (46/508), including new and reclassified findings.
- Open access
AI summary · may contain errors
In pulmonary artery banded pigs, worsening right ventricular dysfunction from RV ejection fraction 38±4% to 20±8% is linked to distinct cellular programs and targetable stress pathways.
- Open access
- 2 cites
AI summary · may contain errors
Quantitative late gadolinium enhancement in hypertrophic cardiomyopathy is independently linked to long-term adverse outcomes, with LGE ≥10% marking substantially higher risk in 3035 patients.
AI summary · may contain errors
Cryab lysine lactylation at K90 is reduced in db/db diabetic cardiomyopathy and, when mutated to K90R, worsens cardiac systolic/diastolic dysfunction, hypertrophy, fibrosis, and apoptosis.
- Open access
AI summary · may contain errors
A 54-year-old woman developed progressive exertional dyspnea due to mitral obstruction caused by a left-sided cardiac sarcoma.
AI summary · may contain errors
Genetic therapies are positioned as a promising future approach for inherited cardiomyopathies, balancing unmet clinical need, patient willingness, and rapid technological advances.
- 1 cites
AI summary · may contain errors
In inducible cardiomyocyte-specific Pkp2 knockout mice, time-resolved proteomics shows early, progressively worsening mitochondrial remodeling, with stronger right-ventricle proteome remodeling despite comparable Pkp2 depletion.
- Open access
AI summary · may contain errors
A novel heterozygous MYBPC1 M-motif variant, c.779G>A p (Arg260His), is linked to CMYO16 in four family members, and oral pyridostigmine showed apparent benefit.
- Open access
AI summary · may contain errors
In an inducible cardiomyocyte-specific Lmna deletion mouse model of LMNA-related dilated cardiomyopathy, blocking mechanically induced nuclear envelope rupture normalizes over half of dysregulated genes and improves survival.
- Open access
- 1 cites
AI summary · may contain errors
LMNA haploinsufficiency from an intronic splice-site variant c.937-1G>A in patient iPSC-derived human cardiac organoids triggers early pro-fibrotic signaling, including increased p38 MAPK phosphorylation.
- Open access
AI summary · may contain errors
E525K β-myosin in gene-edited iPSC-derived cardiomyocytes reduces single-cell contraction by 65% and engineered heart tissue twitch force by 39%, despite increased maximal Ca2+-activated myofibril force by 45%.
- Open access
AI summary · may contain errors
AI-enabled structured cardiac screening frameworks for young people with silent inherited cardiac conditions show great potential for enhancing disease detection and risk prediction.
- Open access
Browse JClub
Journals this month
- bioRxiv6412
- medRxiv1763
- PNAS556
- JAMA353
- Sci Adv330
- Cell Rep315
- Environ Res225
- BMJ217
- EHJ206
- Nat Commun172
- NAR172
- Plant Cell Environ167
- Environ Pollution153
- Science152
- Curr Biol148
- NEJM148
- New Phytol147
- Nature128
Topics moving, week to 17 Nov 2026
- Single-cell and spatial transcriptomics10
- Gut microbiota and health6
- CAR-T cell therapy research6
- Pancreatic and Hepatic Oncology Research5
- Genomics and Chromatin Dynamics5
- Inflammatory Bowel Disease5
- Lung Cancer Treatments and Mutations5
- Antibiotic Resistance in Bacteria5
- Genomics and Phylogenetic Studies4
- Lipoproteins and Cardiovascular Health4
By field
- General Science & Medicine22
- Clinical Medicine25
- Cardiology & Vascular Biology12
- Endocrinology & Metabolism10
- Gastroenterology & Hepatology7
- Public & Global Health4
- Cell & Molecular Biology30
- Immunology & Inflammation14
- Neuroscience14
- Psychiatry & Mental Health8
- Genomics & Bioinformatics29
- Pharmacology & Drug Discovery5
- Microbiology & Mycology34
- Oncology22
- Ecology & Evolution5
- Protected Cropping & Horticultural Science5
- Plant Physiology & Photobiology19
- Student Research1
